{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "NVEC",
  "name": "NVE Corporation",
  "url": "https://orbyd.app/dossiers/NVEC/",
  "json_url": "https://orbyd.app/dossiers/NVEC.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a3",
    "n": 3
  },
  "current_thesis": "Spintronics micro-cap re-rated ~52% in one session on a step-change quarter — revenue +81% to $11.034M, gross margin 81.3%, EPS $1.32 (2026-07-22) — after FY2026 grew just 1.76%. The leg being bought is a structural inflection in sensor/coupler demand from robotics, implantables and semi capex. No guidance, no sell-side anchor; the next test is the Q2 print ~late October.",
  "invalidation_trigger": "A weekly close below $105 surrenders the shelf inside the 2026-07-23 earnings gap and ends the inflection leg; secondarily, a Q2 FY2027 print (~2026-10-21 est.) with product sales below the $10.7M June-quarter level would recast that quarter as a pull-forward.",
  "catalyst_date": "2026-08-31",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "semiconductors-analog",
    "physical-ai-robotics",
    "medtech-diagnostics",
    "small-cap-value-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends March 31 — \"Q1 FY2027\" is the quarter ended 2026-06-30. Third-party data sources label NVE's quarters inconsistently.",
    "4.84M shares outstanding (2026-08-08). Micro-float: realized single-session ranges are wide and quoted depth is thin.",
    "The company issues no formal revenue or EPS guidance and carries no meaningful sell-side coverage, so there is no consensus figure to beat or miss.",
    "The $1.00 quarterly dividend is declared by the board each quarter alongside results rather than under a stated payout policy.",
    "NVE reports quarterly results roughly three weeks after quarter-end, historically in late Jan, Apr, Jul and Oct."
  ],
  "body_markdown": "## Current Thesis\nNVE reported the quarter ended 2026-06-30 on 2026-07-22: revenue $11.034M against $6.100M a year earlier (+81%), product sales $10.7M (+82%), net income $6.39M, diluted EPS $1.32 versus $0.74. Gross margin came in at 81.3% of revenue and operating margin at 66% (Q1 FY2027 call, 2026-07-22). The stock traded +52.4% intraday to $132.07 the following session (Benzinga, 2026-07-23).\n\nThe narrative leg an investor is buying is a step-change in demand for spintronic sensors and couplers — management pointed to existing customers adopting newer products inside \"a strong semiconductor market,\" with robotics and AI applications cited on the call. That claim sits against a company whose FY2026 revenue was $26.33M, up 1.76% over FY2025's $25.87M (stockanalysis.com, 2026-08-08). One quarter has broken a two-year flat line. Nothing yet confirms it repeats: management declined to give guidance and there is no meaningful sell-side estimate to anchor against.\n\n## Bull Case\n- Revenue for the quarter ended 2026-06-30 rose 81% to $11.034M from $6.100M; product sales +82%, contract R&D +53% (release, 2026-07-22).\n- Operating leverage is unusual for the size: 81.3% gross margin, 66% operating margin in the June quarter (Q1 FY2027 call, 2026-07-22). Incremental revenue converts to profit at a rate few analog suppliers reach.\n- Net income $6.39M (+79%), diluted EPS $1.32 vs $0.74 (release, 2026-07-22).\n- TTM revenue has moved to $31.26M, +24.1%, against a FY2026 full year of $26.33M (stockanalysis.com, 2026-08-08) — the trailing line has begun to bend, not just one quarter's print.\n- Product vector with multi-year device cycles: two wafer-level chip-scale sensors for implantable medical devices, roughly one-third the area of the conventionally packaged versions and stable in magnetic fields above 9 Tesla (call, 2026-07-22). Implant design wins, once qualified, are sticky.\n- Capital return did not pause through the inflection: $1.00 per share quarterly dividend declared 2026-07-22, payable 2026-08-31 to holders of record 2026-08-03 — $4.00 annualized, a 3.18% yield (stockanalysis.com, 2026-08-08).\n\n## Bear Case\n- The entire re-rating rests on one observation. Management gave no revenue or EPS guidance, offering only that they were \"very optimistic and extremely pleased\" (call, 2026-07-22). Nothing quantifies whether $11.0M is a quarterly run-rate.\n- Order concentration is implied by management's own framing: \"most of the volume was in existing customers,\" while new customers \"don't move the top line an awful lot\" (call, 2026-07-22). A narrow account base can reverse in a single quarter on distributor ordering patterns.\n- The base rate argues for caution: FY2026 revenue grew 1.76% to $26.33M (stockanalysis.com, 2026-08-08). NVE's revenue history is lumpy, and the June quarter is far above the FY2026 average quarterly rate.\n- Valuation already discounts continuation — market cap $609.19M and a 33.85 P/E on 4.84M shares outstanding (stockanalysis.com, 2026-08-08) for a business that did $26.33M of revenue last fiscal year.\n- No sell-side estimate channel means no institutional anchor; price discovery in this name is flow-driven, which is what a +52.4% single session on 4.84M shares looks like (2026-07-23).\n- The 2026-07-23 gap is unfilled. That session printed $105.00 in pre-market (+21.1%) before reaching $132.07 intraday (Benzinga, 2026-07-23), leaving a wide unrepaired zone beneath the current range.\n- Isolation and magnetic sensing are contested by far larger process owners — Analog Devices, Broadcom and Silicon Labs in digital isolators, Allegro, TDK and Infineon in magnetic sensing. An 81.3% gross margin invites attack.\n\n## Setup & Price Structure\n- Last completed daily close $125.94 (2026-08-07), 52-week high $133.06, so the name sits 5.4% below its high with a three-month return of +42.4% and RSI(14) at 71.6.\n- Behaviour since the print is the constructive part: after the 2026-07-23 session peaked at $132.07, price has held near the high through 2026-08-07 rather than retracing into the gap. Two weeks of range-holding after a 50%+ repricing is absorption rather than distribution, though the sample is short.\n- Overhead reference: $132.07 (2026-07-23 intraday) and the $133.06 52-week high. The nearest observable shelf below is $105.00, the level the stock printed in the 2026-07-23 pre-market session before the gap extended. Between $105 and the current range there is no established volume structure.\n- **Life-cycle: ACCELERATING.** Dating it: the 2026-07-22 print, three separate Benzinga movers items on 2026-07-23, inclusion in Benzinga's \"Stock Whisper\" index on 2026-08-01, and price within 5.4% of the 52-week high on 2026-08-07. Attention here is new. The qualifier is that with no meaningful analyst coverage, acceleration has no estimate-revision channel to run through — the bid has to come from discretionary and retail flow.\n- Crowding and positioning observables, stated without a verdict: RSI(14) 71.6 (2026-08-07); +42.4% over three months; retail-sentiment aggregator coverage clustering on 2026-08-01; no earnings date inside the next 30 days to compress positioning; no Form 4 or other filings surfaced in the trailing 30-day window; the dividend record date passed 2026-08-03, so shares already trade ex the August payment.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-31** — $1.00 per share quarterly dividend payable, record date 2026-08-03. A cash event; it carries no new information about demand, and the record date is already behind the tape.\n- **~2026-10-21 (est.)** — Q2 FY2027 results for the quarter ending 2026-09-30. Outside the 30-day window. This is the first observation that tests the June quarter, and there is no scheduled company event before it.\n- No confirmed conference appearances, product launches or regulatory dates fall inside the window. The next 30 days are an information vacuum for this name.\n\n## What Would Change Our Mind\nDurability is the single point of failure. The re-rating capitalizes one quarter of $11.034M revenue against a FY2026 base of $26.33M that grew 1.76%. A Q2 FY2027 print (~2026-10-21 est.) showing product sales materially below the $10.7M June-quarter level would recast June as a distributor pull-forward and remove the basis for the multiple, regardless of where price sits at the time.\n\nOn structure, a weekly close below $105 gives up the shelf where the 2026-07-23 gap opened and would mark the inflection leg as failed; the zone between there and the current range has no volume history to arrest a decline.\n\nA gross margin printing below 78% in a subsequent quarter would suggest the 81.3% June figure reflected mix rather than pricing power. An insider Form 4 showing sales into this range would be an observable that the informed side is monetizing the re-rating. And if retail-aggregator coverage keeps clustering while the range stops making higher highs above $133.06 through September, the theme has moved toward SATURATED without the fundamentals confirming.\n\n## Correlation Notes\n- Closest listed reference points are Allegro MicroSystems in magnetic sensing and Analog Devices and Silicon Labs in digital isolation, where NVE's spintronic couplers compete with optocoupler and capacitive-isolator incumbents. The analog/industrial semiconductor cycle sets the backdrop management described as \"a strong semiconductor market\" (call, 2026-07-22).\n- The implantable-device exposure ties part of demand to medical OEM volumes — pacing and neuromodulation build rates — a cycle that runs independently of AI capex and can offset or mask a robotics-driven quarter.\n- With 4.84M shares outstanding (2026-08-08), the name is a liquidity outlier. Single-session moves above 20% are inside its realized behaviour (2026-07-23), and small-cap and index flows can dominate fundamentals on any given day in both directions.\n- The $4.00 annualized dividend gives NVEC a rate-sensitive holder base that pure micro-cap growth names lack. Yield holders and momentum holders exit on different signals, which can make the tape discontinuous around dividend and earnings dates.",
  "first_seen": "2026-08-07",
  "last_analyzed": "2026-08-08T09:40:27+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}